These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Thalidomide neuropathy in childhood. Fleming FJ; Vytopil M; Chaitow J; Jones HR; Darras BT; Ryan MM Neuromuscul Disord; 2005 Feb; 15(2):172-6. PubMed ID: 15694139 [TBL] [Abstract][Full Text] [Related]
5. The role of thalidomide in the treatment of refractory chronic graft-versus-host disease following bone marrow transplantation in children. Rovelli A; Arrigo C; Nesi F; Balduzzi A; Nicolini B; Locasciulli A; Vassallo E; Miniero R; Uderzo C Bone Marrow Transplant; 1998 Mar; 21(6):577-81. PubMed ID: 9543061 [TBL] [Abstract][Full Text] [Related]
6. Clinical and electrophysiological evaluation of patients with thalidomide-induced neuropathy. Kocer B; Sucak G; Kuruoglu R; Aki Z; Haznedar R; Erdogmus NI Acta Neurol Belg; 2009 Jun; 109(2):120-6. PubMed ID: 19681443 [TBL] [Abstract][Full Text] [Related]
8. Development of neuropathy in patients with myeloma treated with thalidomide: patterns of occurrence and the role of electrophysiologic monitoring. Mileshkin L; Stark R; Day B; Seymour JF; Zeldis JB; Prince HM J Clin Oncol; 2006 Sep; 24(27):4507-14. PubMed ID: 16940275 [TBL] [Abstract][Full Text] [Related]
9. [Thalidomide and graft verses host disease: basis for a new indication and side effects]. López Gil JA Med Clin (Barc); 1992 Oct; 99(14):545-8. PubMed ID: 1434991 [No Abstract] [Full Text] [Related]
10. [Electrophysiologic changes in thalidomide neuropathy in the treatment of discoid lupus erythematosus]. Ludolph A; Matz DR EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb; 1982 Dec; 13(4):167-70. PubMed ID: 6295739 [TBL] [Abstract][Full Text] [Related]
12. Neuropathy in multiple myeloma treated with thalidomide: a prospective study. Plasmati R; Pastorelli F; Cavo M; Petracci E; Zamagni E; Tosi P; Cangini D; Tacchetti P; Salvi F; Bartolomei I; Michelucci R; Tassinari CA Neurology; 2007 Aug; 69(6):573-81. PubMed ID: 17679676 [TBL] [Abstract][Full Text] [Related]
13. Thalidomide--the need for a new clinical evaluation of an old drug. Ehninger G; Eger K; Stuhler A; Schuler U Bone Marrow Transplant; 1993; 12 Suppl 3():S26-8. PubMed ID: 8124253 [TBL] [Abstract][Full Text] [Related]
14. Life-threatening acute pancreatitis due to thalidomide therapy for chronic graft-versus-host disease. Chung LW; Yeh SP; Hsieh CY; Liao YM; Huang HH; Lin CY; Chiu CF Ann Hematol; 2008 May; 87(5):421-3. PubMed ID: 18040684 [No Abstract] [Full Text] [Related]
15. Thalidomide in Crohn disease and the risk of peripheral neuropathy. Ahmed M; El-Hadi S; Jenkins HR J Pediatr Gastroenterol Nutr; 2003 Oct; 37(4):522. PubMed ID: 14508228 [No Abstract] [Full Text] [Related]
16. Thalidomide-induced neuropathy: treatment by decompression of peripheral nerves. Rose MI; Rosson GD; Elkwood AI; Dellon AL Plast Reconstr Surg; 2006 Jun; 117(7):2329-32. PubMed ID: 16772938 [No Abstract] [Full Text] [Related]
17. The troublesome toxicity of peripheral neuropathy with thalidomide. Mileshkin L; Prince HM Leuk Lymphoma; 2006 Nov; 47(11):2276-9. PubMed ID: 17107897 [No Abstract] [Full Text] [Related]
18. Thalidomide back in good graces--seems to help GVHD patients. Oncology (Williston Park); 1988 Sep; 2(9):29. PubMed ID: 3275064 [No Abstract] [Full Text] [Related]
19. [Polyneuritis and polyneuropathies due to drug therapy]. Suchenwirth R Rev Clin Esp; 1968 Sep; 110(6):537-9. PubMed ID: 4310213 [No Abstract] [Full Text] [Related]